Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer
Open Access
- 9 May 2015
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 8 (1) , 1-8
Abstract
Lysine-specific demethylase 1(LSD1) is implicated in the tumorigenesis and progression in various cancers. However, the expression of LSD1 in epithelial ovarian cancer and its clinical significance has not been examined in detail. Immunohistochemical was used to detect the expression of LSD1 in normal ovarian epithelial tissues, cystadenoma, borderline cystadenoma, and cystadenocarcinoma. Next, the correlations between expression of LSD1 and clinicopathological features was assessed in 96 species of serous cystadenocarcinoma and 36 species of mucinous cystadenocarcinoma. Immunohistochemical results showed that the expression of LSD1 was gradually increased from benign cystadenoma and borderline cystadenoma to cystadenocarcinoma. The positive ratio of LSD1 expression was 50% in normal ovarian epithelial tissues, 72% in serous cystadenoma, 73% in mucinous cystadenoma, 82% in borderline serous cystadenoma, 83% in borderline mucinous cystadenoma, 94% in serous cystadenocarcinoma and 92% in mucinous cystadenocarcinoma, respectively. LSD1 expression levels were associated with International Federation of Gynecology and Obstetrics stage and lymphatic metastasis in both serous and mucinous cystadenocarcinoma samples. Kaplan-Meier curves suggested that overall survival time of patients with high LSD1 expression was significantly shorter than that of patients with low LSD1 expression. Multivariate Cox proportional hazard regression indicated that higher LSD1 expression was a significant independent predictor of poor survival of EOC patients (P = 0.016). These results suggest that LSD1 may be involved in carcinogenesis and progression with promising therapeutic potential for epithelial ovarian cancer.Keywords
This publication has 21 references indexed in Scilit:
- LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancerBritish Journal of Cancer, 2013
- Analysis of the levels of lysine-specific demethylase 1 (LSD1) mRNA in human ovarian tumors and the effects of chemical LSD1 inhibitors in ovarian cancer cell linesJournal of Ovarian Research, 2013
- Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent mannerBiochemical Journal, 2012
- Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breastBMC Clinical Pathology, 2012
- Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung CancerPLOS ONE, 2012
- Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patientsWorld Journal of Gastroenterology, 2012
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancersInternational Journal of Cancer, 2010
- Genetic alterations and changes in expression of histone demethylases in prostate cancerThe Prostate, 2010
- Ovarian CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005